JUL 26, 2017 4:12 PM PDT

Immune Cells Compete Against Each Other for Survival

WRITTEN BY: Kara Marker

A study that was initially designed to simply study T cell homeostasis ended up yielding surprising results. A recently discovered cell type, innate lymphoid cells (ILCs), appeared to be better at securing proteins both ILCs and T cells need to survive. This finding is perplexing because while T cells are plentiful in the body, ILCs are extremely rare.

Innate lymphoid cells (ILCs, in gray) outcompete and exert a measurable control on the survival of the abundant T-cells (pink). This is possible because T cells decrease the number of IL-7 receptors (IL-7R, represented as butterfly nets) after binding IL-7, while ILCs do not. Credits: IBS, modified from freepiks.com

The study was a collaboration between the Institute for Basic Science, La Jolla Institute for Allergy and Immunology, and The Scripps Research Institute. Researchers are interested in understanding more about immune cell homeostasis, especially T cells and B cells, due to their vital role in vaccine effectiveness and in keeping the human body health even as it ages.

T cells need to bind a protein called interleukin-7 (IL-7) to survive, and they have an IL-7 receptor on their cell surface just for this purpose. In the past, scientists had trouble studying T cell homeostasis because it is difficult to measure levels of IL-7 in the lab. But in the current study, scientists found a way around this roadblock to study how the body regulates IL-7 production.

Starting with mice lacking any IL-7 receptors, researchers saw IL-7 proteins begin to accumulate in the mice models, since they had nothing to bind. Then, they reintroduced cells with IL-7 receptors and watched how the mice immune systems reacted. This is where they saw that T cells were not the only cell binding IL-7; ILCs were also binding IL-7 and binding it more effectively.

"To be honest, I was quite surprised that ILCs have such an effect in this model," said lead author, Christopher Martin. "Relative to T cells, there are very few ILCs in the tissues we study. So, when we were designing the initial experiments, we weren't optimistic that we would find anything interesting."

Now with ILCs in the picture, we have to wonder: Why isn’t there enough IL-7 for both these cells? Why do they need to compete? While these questions have yet to be answered, the study scientists do know why ILCs are better at binding IL-7. While T cells decrease the number of IL-7 receptors as they start to bind IL-7, ILC’s don’t, and they can continue binding IL-7 at a rate faster than T cells.

Creating healthy levels of both T cells and ILCs is important for fighting pathogens, making vaccines work, and preparing for good health in old age, when natural production of immune cells slowly diminishes. If scientists can understand why these two cell types have to compete for survival, perhaps they can find a way for both to flourish in harmony.

The present study was published in the journal Immunity.

 

Source: Institute for Basic Science

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 07, 2019
Immunology
SEP 07, 2019
A New Way To Fight Severe Peanut Allergies
Dr. Sandra Lin explains how SLIT is currently being used to treat allergies other than peanuts.    Over 1 million U.S. children have an allergy t...
OCT 31, 2019
Cancer
OCT 31, 2019
Unpacking lactate's role in the Warburg effect
In a recent issue of Nature, the findings of one study made a particularly big splash: how and why cancer cells use energy differently than healthy cells. ...
NOV 20, 2019
Immunology
NOV 20, 2019
Harnessing the Power of Natural Killer Cells to Fight Cancer
Manipulating the immune system’s population of natural killer cells could bolster therapies targeting cancer. A new study saw positive results invest...
NOV 29, 2019
Immunology
NOV 29, 2019
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ...
DEC 04, 2019
Immunology
DEC 04, 2019
Predicting Death with Clinical Immune Indicators
Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a new study mark the first step toward...
JAN 14, 2020
Clinical & Molecular DX
JAN 14, 2020
Can I eat this donut? A quick test for celiac disease.
Genetic testing revealed that our ancestors have been eating wheat, rye, spelt and barley for over 8,000 years. Today, gluten, a protein found within these...
Loading Comments...